Newsroom

Sorted by: Latest

-

Blood Collection Tubes Market Insights, 2025-2032 - Rising Demand for Advanced Additive Formulations and Traceability Features Driving Strategic Investment Across Clinical Supply Markets - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blood Collection Tubes Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Blood Collection Tubes Market is evolving swiftly to address the increasing complexity of diagnostic demands and supply chain expectations within modern healthcare ecosystems. As clinicians and laboratories pursue operational efficiency and accuracy, industry stakeholders are prioritizing solutions that integrate workflow innovation with compli...
-

State Street to Match U.S. Treasury Contributions to New Child Savings Accounts

BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) today announced a new program to match U.S. Treasury contributions to the children’s savings accounts established under the Working Family Tax Cuts initiative. The initiative, designed to promote long-term savings and investment for children under 18 years old, will be administered by the U.S. Treasury and is set to launch on July 4, 2026, in conjunction with the 250th anniversary of the United States’ Declaration of Independence. St...
-

Online Language Learning Market Forecast 2025-2032: Total Revenues to Grow by $41 Billion, Driven by Surge in Microlearning Modules Designed for On-The-Go Professionals Seeking Quick Language Drills - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Online Language Learning Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The online language learning market is transforming workforce training and global collaboration for enterprises. Enhanced digital solutions are enabling organizations to upskill talent, drive operational efficiency, and meet the demands of an increasingly multilingual, cross-border business landscape. Market Snapshot: Online Language Learning Mar...
-

Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump’s action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act. “Today marks the most consequential moment in the history of U.S. cannabis. The decision to move cannabis from Schedule I to Schedule III will be a cultural turning point, ackn...
-

SIIA Consumer Survey on Data Privacy Reveals People Want to Be Primary Stewards of Their Own Data

WASHINGTON--(BUSINESS WIRE)--SIIA releases consumer survey results on insights and attitudes about data privacy and comfort with various data uses under different conditions....
-

Xsolla Announces Scholarship Program to Support 45 Developers at the GDC Festival of Gaming 2026

LOS ANGELES--(BUSINESS WIRE)--Xsolla, a leading global video game commerce company, announces the launch of the GDC Festival of Gaming 2026 Scholarship Program - Powered by Xsolla, an initiative designed to support indie and mid-tier developers who face financial limitations preventing them from attending the GDC Festival of Gaming in San Francisco. As GDC celebrates its 40th edition and enters a new era designed to drive connection, discovery, and collaboration for everyone who imagines, build...
-

Riassunto: BeOne Medicines ha ricevuto la designazione Fast Track dall'FDA statunitense per BGB-B2033 come trattamento per il carcinoma epatocellulare

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), società oncologica globale, oggi ha annunciato che la Food and Drug Administration (FDA) statunitense ha concesso la designazione Fast Track aziendale per BGB-B2033, il suo anticorpo bispecifico GPC3x4-1BB per il trattamento del carcinoma epatocellulare (HCC) in pazienti adulti con progressione della malattia o già sottoposti in precedenza a trattamento sistemico. Il testo originale del presente a...
-

Samenvatting: BeOne Medicines ontvangt Amerikaanse FDA Fast Track-status voor BGB-B2033 als behandeling voor hepatocellulair carcinoom

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), een wereldwijd oncologiebedrijf, heeft vandaag bekendgemaakt dat de Amerikaanse Food and Drug Administration (FDA) het bedrijf de Fast Track-status heeft toegekend voor BGB-B2033, het bispecifieke GPC3x4-1BB-antilichaam voor de behandeling van volwassen patiënten met hepatocellulair carcinoom (HCC) met ziekteprogressie tijdens of na eerdere systemische behandeling. Deze bekendmaking is officieel g...
-

Des résultats record au CIIE 2025 témoignent d’une dynamique mondiale croissante

SHANGHAI--(BUSINESS WIRE)--La huitième édition de la China International Import Expo (CIIE) s’est achevée sur des résultats record, illustrant son influence mondiale grandissante ainsi que l’engagement continu de la Chine en faveur de l’ouverture. Durant les six jours de l’événement, l’expo a accueilli 922 000 visites — un record absolu, en hausse de 8,2 % par rapport à l’année précédente. Les intentions d’achat sur un an ont atteint 83,49 milliards de dollars, soit une progression de 4,4 % en...
-

Record-breaking CIIE 2025 Achievements Signal Global Momentum

SHANGHAI--(BUSINESS WIRE)--The eighth China International Import Expo (CIIE) has concluded with record results, underscoring its growing global influence and China’s commitment to openness. Over six days, the expo welcomed 922,000 visits—an all-time high and an 8.2% increase from last year. Intended one-year purchase deals reached $83.49 billion, up 4.4% year-on-year. With 4,108 exhibitors from 138 countries and regions in attendance—the broadest participation to date—this turnout highlighted s...